TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Cash Flow
NASDAQ:TNXP - Nasdaq - US8902608392 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -131.93M | -130.04M | -116.66M | -110.22M | -92.29M | |||
| Depreciation Amortization | 2.70M | 3.42M | 4.29M | 1.25M | 50.00K | |||
| Change In Working Capital | 1.33M | 5.78M | -35.00K | 0.00 | 5.78M | |||
| Interest Paid | N/A | 1.23M | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 67.97M | 59.91M | 10.40M | 10.91M | 10.90M | |||
| OPERATING CASH FLOW | -59.93M | -60.92M | -102.00M | -98.05M | -75.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -18.00K | -120.00K | -7.89M | -48.15M | -35.31M | |||
| Other Investing Activity | N/A | N/A | -21.18M | N/A | N/A | |||
| INVESTING CASH FLOW | -18.00K | -120.00K | -29.07M | -48.15M | -35.31M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -11.77M | -2.35M | 8.94M | N/A | N/A | |||
| Stock Issued/Repurchased | 199.38M | 140.22M | 27.57M | 87.84M | 212.49M | |||
| Other Financing Activity | N/A | -3.00M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 184.62M | 134.87M | 36.52M | 87.84M | 212.49M | |||
| Exchange Rate Effect | -1.00K | 4.00K | -65.00K | -70.00K | -30.00K | |||
| CHANGE IN CASH | 124.67M | 73.83M | -94.62M | -58.43M | 101.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -59.93M | -60.92M | -102.00M | -98.05M | -75.56M | |||
| Capital Expenditure | -18.00K | -120.00K | -7.89M | -48.15M | -35.31M | |||
| FREE CASH FLOW | -59.95M | -61.05M | -109.90M | -146.20M | -110.87M | |||
All data in USD